News & Analysis as of

MedPAC Executive Orders Food and Drug Administration (FDA)

Holland & Knight LLP

Holland & Knight Health Dose: March 3, 2026

Holland & Knight LLP on

U.S. Congress returns to session this week after the U.S. military launched strikes against Iran and defended against retaliatory actions against U.S. military personnel and presences across the Middle East. Both the U.S....more

Holland & Knight LLP

Holland & Knight Health Dose: January 13, 2026

Holland & Knight LLP on

The U.S. House of Representatives has passed a bill to extend the enhanced advanced premium tax credits (APTCs) for three years following a 230-196 vote, with 17 Republicans voting with Democrats to support its passage. The...more

Holland & Knight LLP

Holland & Knight Health Dose: June 17, 2025

Holland & Knight LLP on

The U.S. Senate is in session for three days this week while the U.S. House of Representatives is in recess all week. Both chambers will return for a week before breaking for the July 4 recess. Negotiations on the...more

Mintz - Health Care Viewpoints

Biden Administration’s Drug Pricing Plan Calls for Bold Action by Congress

It’s finally here – the Drug Pricing Plan that President Biden ordered the Department of Health and Human Services (HHS) to produce by the end of August (the “Plan”) was released publicly by the Administration on September 9,...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide